In contrast with OpenAI, which follows a closed model, DeepSeek’s AI model discloses its full chain of reasoning in an open ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

propelling the market for life-extending therapeutics into a $25 billion business. OpenAI CEO Sam Altman (left), Amazon’s Jeff Bezos (center), and PayPal cofounder Peter Thiel (right ...

Sam Altman has been accused of s*xual abuse in a ... The lawsuit mentioned that Annie could not enjoy a normal life because of the alleged abuse and that Sam reportedly made Annie believe that ...

Altman does not own direct equity in OpenAI, but rather has an indirect interest in OpenAI through a small investment made by a fund in startup accelerator Y Combinator. Sam Altman is a ...

OpenAI chief executive Sam Altman, who provided the initial $180mn ... which will be tested in an early stage study in Australia this year. It is also working on drugs for rejuvenating blood ...

The biggest stories of the day delivered to your inbox.

Sam Altman wrote a blog post about his experience running OpenAI on Sunday. Altman said OpenAI would have fallen apart in 2023 without Ron Conway's and Brian Chesky's help. That was the year Altman ...

The race to increase human life span through ... that’s set to enter an early-stage trial in Australia this year. Some of the investment will come from OpenAI CEO Sam Altman, who also provided ...